![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Misonix Announces Approval of Sonablate, Neuroaspirator Products
Misonix Announces Approval of Sonablate, Neuroaspirator Products
April 26, 2005
Misonix, a developer of ultrasonic medical device
technology for the treatment of cancer and other healthcare purposes, announced
that both the Sonablate 500 product used for the treatment of prostate cancer
and its FS1000 Neuroaspirator for soft tissue removal used primarily in neurosurgery
have received approval from the Russian Federation. This approval certifies
that the products are fully registered and certified for sale and use for their
stated applications within the Russian Federation.
Yahoo
News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct